ArticleImaging neuroscience (Cambridge, Mass.)
Unveiling unified patterns in Alzheimer's disease subtypes: An SCCA clustering approach integrating PET imaging and genomics data.
Article in Imaging neuroscience (Cambridge, Mass.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multimodal axes reveal individualized amyloid-medRxiv : the preprint server for health sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Alzheimer's disease (AD) is the most common cause of dementia and a significant public health challenge. AD is characterized by the formation of tau and beta-amyloid (Aβ) protein aggregates in the brain, which can be imaged in vivo using positron emission tomography (PET). Integrating genetic and neuroimaging data using imaging genetics tools offers the potential to better understand disease mechanisms and risk factors in this heterogeneous disorder. Here, we present a framework based on Sparse Canonical Correlation Analysis (SCCA) integrated with clustering to identify AD subtypes from PET and genomic data. The SCCA clustering method was applied to tau PET scans (N = 541), Aβ PET scans (N = 907), and corresponding genomics data from the Alzheimer's Disease Neuroimaging Initiative database. Test-retest studies were used to compare two different SCCA implementations, and longitudinal data were used to assess the stability of the subtyping approach. We identified four tau subtypes and two Aβ subtypes with distinct spatial deposition patterns, consistent with prior imaging studies. Genetic profiles associated with each subtype showed enrichment of specific biological pathways. Our findings suggest that SCCA clustering can help reveal biologically meaningful subtypes of AD. A clearer understanding of AD subtypes could ultimately improve AD diagnosis, prognosis, and treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.